Bannister; Steve J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bannister; Steve J..The latest application filed is for "multi-dose concentrated liquid diphenhydramine hcl compositions and packaged multi-dose liquid diphenhydramine hcl formulations".

Company Profile

1.4.6

Bannister; Steve J. - Tampa FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Packaged multi-dose liquid dextromethorphan hydrobromide formulation Grant 11,234,897 - Thuesen , et al. February 1, 2	2022-02-01
Multi-Dose Concentrated Liquid Diphenhydramine HCl Compositions and Packaged Multi-Dose Liquid Diphenhydramine HCl Formulations App 20210069127 - Thuesen; Mark Lawrence ; et al.	2021-03-11
Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation Grant 10,369,105 - McChesney , et al.	2019-08-06
Packaged Multi-Dose Liquid Drug Formulation App 20180271746 - Thuesen; Mark Lawrence ; et al.	2018-09-27
Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation Grant 10,064,823 - McChesney , et al. September 4, 2	2018-09-04
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation App 20180235883 - McChesney; James D. ; et al.	2018-08-23
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation App 20170042815 - McChesney; James D. ; et al.	2017-02-16
Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation Grant 9,468,603 - McChesney , et al. October 18, 2	2016-10-18
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation App 20150079189 - McChesney; James D. ; et al.	2015-03-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.